Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Clinical trial NCT06603623 · COMPLETED
Trial details
- NCT number
- NCT06603623
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2025-03-24
- Enrollment
- 647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.